InvestorsHub Logo
Followers 7
Posts 5499
Boards Moderated 0
Alias Born 09/11/2013

Re: None

Tuesday, 04/10/2018 2:18:30 PM

Tuesday, April 10, 2018 2:18:30 PM

Post# of 146240
Do folks really still believe NNVC is trying to develop drugs? Isn't it obvious they are in the end game, just biding time until the Cash-$0 event?

In summary:
If management try (or tried) to add another (new) herpes drug candidate at this point...it will take (or would have taken) a while. So I don't think it happened.
If they are trying to pursue two or three indications rather than just shingles in upcoming human trials, that will delay the start of human trials by at least 9 months (and more likely 18 months or more). I would not put it beyond management to do this, even though it could cause a serious hit to the share price for an equity raise.
I'm hoping they will go forward with human trials using just one drug for just one indication (shingles). Taking a second drug through formal tox testing (small and large animals) would cost in the neighborhood of an additional $500K, so it's not a totally unreasonable possibility.


Who are "they" and why are they always saying how I should be doing things?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News